HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

ed by dysfunction in areas of language, social interaction and behavior. The condition is four times more likely to occur in boys than in girls, and is often diagnosed between the ages of 18 to 30 months, during the same age that children in the United States receive the typical battery of 21 vaccinations.

Not enough definitive research exists to prove or refute a link between the measles vaccine and the subsequent development of autism in a child. However, the powerful anecdotal evidence from parents demands an answer that can only be ascertained through credible research, says Rall.

Rall points out the remarkable benefits of vaccines for most children and he remains a strong advocate for their use. When children are not vaccinated, they are left vulnerable to potentially fatal diseases. According to the National Coalition for Adult Immunization, measles virus continues to be a significant cause of mortality worldwide, resulting in over a million deaths annually, many of which could be prevented by vaccination.

Rall, an expert in viruses of the central nervous system, has been working in the virology and immunobiology laboratories at Fox Chase Cancer Center since 1995 where he investigates the causes and mechanisms of central nervous system diseases. In addition to his current work with the M.I.N.D Institute, he has also worked with The F.M. Kirby Foundation, investigating Lou Gehrigs Disease. He received his Ph.D. in 1990 from Vanderbilt University in Nashville and has authored many scientific publications as well as being the recipient of numerous awards and grants.


'"/>

Contact: Sue Montgomery Madden
S_Madden@fccc.edu
215-728-7784
Fox Chase Cancer Center
10-Apr-2002


Page: 1 2

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
3. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
6. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
7. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
8. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
9. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
10. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
11. Fox Chase Cancer Center researchers make significant discovery about function of p53

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/19/2019)... ... 2019 , ... The Laser Institute (LIA)'s 38th ... held in Orlando, Florida and featured the conference’s many firsts. A meeting of ... with a deeper industry foci, more expansive technical sessions, and a new Business ...
(Date:10/17/2019)... , ... October 15, 2019 , ... ... Media for the Microbiological Community”. , Microbiology International currently manufactures ready-to-use culture broth ... also offers pre-poured agar plates & liquid supplements. , This major step underpins ...
(Date:10/17/2019)... ... October 16, 2019 , ... The International Society for ... Baseline® Guide: Water and Steam Systems (Third Edition) . This guide provides in-depth ... systems. Industry professionals can better understand Good Manufacturing Practices (GMPs), to comply with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the ... that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now ... demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 17, 2019 , ... Catalent, a global leader in clinical ... Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials ... On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s ...
Breaking Biology Technology:
Cached News: